31.01.2021, 2552 Zeichen

Frequentis: Latvian Air Navigation Services, Latvijas Gaisa Satiksme (LGS) selected Frequentis California to enhance its pilot briefing services to increase flight planning efficiency and safety, as well as ease of use for pilots. The Frequentis Integrated Briefing System, smartIBS, was put into operation on December 3, 2020. The system includes new tools to ease pilot access to airspace and weather information, as well as cybersecurity upgrades, and is accessible via web browsers, smartphones and tablets.
Frequentis: weekly performance: -2.19%

AT&S: The audio glasses “Fauna”, from the Austrian startup Fauna (available at wearfauna.com), are not only a designer piece made of high-quality material, fashionable frame shapes and colors, but also a technological masterpiece: four integrated micro speakers and two microphones ensure that music, podcasts, audio books and even phone calls are comfortably possible via the glasses. The glasses are charged with a charging case that also doubles as a power bank. The circuit board on which the micro-speakers are mounted is produced by the Styrian high-tech company AT&S – one of the global market leaders in high-quality interconnection solutions.
AT&S: weekly performance: -6.57%

Valneva:  Valneva SE, an Austrian/French specialty vaccine company focused on prevention of infectious diseases with significant unmet medical need, today announced it has commenced production of its inactivated, adjuvanted COVID-19 vaccine candidate in parallel to the ongoing clinical studies, in order to optimize the timeline for potential deliveries of the vaccine. The Phase 1/2 clinical study is now fully enrolled and is expected to report initial results in April 2021. VLA2001 is currently the only inactivated vaccine candidate in clinical trials against COVID-19 in Europe. A total of 150 healthy adults aged 18 to 55 years have been recruited for the Phase 1/2 study which commenced mid December 20201. In September 2020, Valneva announced a major COVID-19 vaccine partnership with the UK government for the supply of up to 190 million doses of its COVID-19 vaccine VLA20012. Under this partnership agreement, if vaccine development is successful, Valneva will provide the UK government with 60 million doses in the second half of 2021. Valneva also announced in January 20213 it is in advanced discussions with the European Commission for the supply of up to 60 million doses of VLA2001.
Valneva: weekly performance: 4.41%

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (28/01/2021)

Christian Drastil: Wiener Börse Plausch

SportWoche ÖTV-Spitzentennis Podcast: Anastasia Potapova erobert unsere Nr. 1-Position und die Herzen der österreichischen Tennisfans

Bildnachweis

Aktien auf dem Radar:Rosenbauer, RBI, DO&CO, Semperit, Austriacard Holdings AG, EuroTeleSites AG, Porr, Amag, Andritz, AT&S, VIG, Uniqa, Palfinger, Polytec Group, Marinomed Biotech, OMV, Addiko Bank, Erste Group, Flughafen Wien, Lenzing, Mayr-Melnhof, RWT AG, Strabag, Wienerberger, BKS Bank Stamm, BTV AG, Oberbank AG Stamm, CA Immo, CPI Europe AG, Österreichische Post, Telekom Austria.

---